PBPH
Portfolio Building Block World Pharma And Biotech Index ETF
Price Chart
Latest Quote
$27.19
+0.06 (+0.21%)
Current Price
| Previous Close | $27.13 |
| Open | $27.25 |
| Day High | $27.42 |
| Day Low | $27.09 |
| Volume | 72,132 |
Fund Information
| Net Assets | $859.37M |
| Expense Ratio | 0.13% |
| Category | Health |
| Fund Family | Portfolio Building Block ETFs |
| Net Asset Value | $27.09 |
| Premium/Discount | 0.38% |
| P/E Ratio | 24.90 |
| Exchange | NGM |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $26.92 |
| SMA50 | $26.00 |
| RSI | 50.39 |
| ATR | 0.4349 |
| Rel Volume | 0.28 |
Performance History
| Week | +0.38% |
| Month | +5.93% |
| Quarter | +6.92% |
| 6 Months | +5.02% |
| YTD | +7.43% |
| 10 Years | +9.81% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $27.19 | 72,132 |
| 2026-07-16 | $27.15 | 78,900 |
| 2026-07-15 | $26.73 | 87,300 |
| 2026-07-14 | $26.60 | 78,500 |
| 2026-07-13 | $26.99 | 65,600 |
| 2026-07-10 | $27.09 | 81,100 |
| 2026-07-09 | $27.46 | 88,100 |
| 2026-07-08 | $27.63 | 81,200 |
| 2026-07-07 | $28.04 | 78,600 |
| 2026-07-06 | $27.59 | 89,100 |
| 2026-07-02 | $27.91 | 1,994,100 |
| 2026-07-01 | $27.02 | 1,656,800 |
| 2026-06-30 | $27.18 | 68,800 |
| 2026-06-29 | $27.43 | 91,800 |
| 2026-06-26 | $27.16 | 116,600 |
| 2026-06-25 | $26.43 | 92,200 |
| 2026-06-24 | $26.10 | 90,700 |
| 2026-06-23 | $25.91 | 68,400 |
| 2026-06-22 | $25.55 | 102,200 |
| 2026-06-18 | $25.25 | 82,100 |
About Portfolio Building Block World Pharma And Biotech Index ETF
The fund uses a “passive management” approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund’s net assets in component securities that make up the index. The fund is non-diversified.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.